---
title: Assessing Response for Nivolumab Plus Ipilimumab in Squamous Cell Carcinoma
  of the Head and Neck
date: '2023-11-22'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37991743/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20231123171003&v=2.17.9.post6+86293ac
source: heidelberg[Affiliation]
description: No ...
disable_comments: true
---
No ...